OPPapers.com Essay Index >> Business >> The Pharmaceutical Industry And The Aids Crisis In Developing Countries
We have many free term papers and essays on The Pharmaceutical Industry And The Aids Crisis In Developing Countries. We also have a wide variety of research papers and book reports available to you for free. You can browse our collection of term papers or use our search engine.
The Pharmaceutical Industry and the AIDS Crisis in Developing Countries. The
Pharmaceutical Industry and the AIDS Crisis in Developing ...
... critical press of the pharmaceutical industry put a lot ... Even though GSK and other
pharmaceutical companies lowered ... coverage of its response to the AIDS crisis. ...
... with anti- AIDS medication, developing countries must ... A holistic approach to the
AIDS crisis should include ... so that the pharmaceutical industry could maintain ...
... Despite the onset of the AIDS crisis within impoverished Africa, highly ... Life, Death,
and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa ...
... a harsh blown from the crisis of the ... Aug, 2007) • Forecasting for the Pharmaceutical
Industry : models for ... 2007) Appendices Global HIV/AIDS estimates, end of ...
Submitted by fortknight on July 7, 2007
Category: Business
Words: 1837 | Pages: 8
Views: 234
Popularity Rank: 47,989
Average Member Grade: N/A (Add a Comment / Grade this Paper)
The Pharmaceutical Industry and the AIDS Crisis in Developing Countries
· Describe the nature of supplying drugs to emerging markets at an affordable price without undermining their profits
· Research and analyse in depth the effectiveness of one proposed policy response to this issue.
Introduction
1 2001 saw a flurry of events, as highlighted in the excepts of the case study, which caused an awareness by the international community of the inequality between rich and poor nations in the care and treatment of people living with HIV/AIDS.
2 Epitomized by the lawsuit against the South African government, the drug companies "want desperately to be seen helping fight the global AIDS crisisÂ… but the companies also remain unwavering in their defense of patents, even if it means suing poor nations that want to make or buy bootleg generics because they can't afford brand-name drugs." The episode not only represents a "moral scandal", but also a major economic, political and social challenge. Can the needs of the poor be met through increased access to the drugs, without necessarily hurting the profits of the drug companies?
Past Trends and New Developments
3 The following table summarizes the price changes for brand and generic drugs from 2000 to 2001 (IAEN).
Patents and Monopoly Power
4 Prices charged by pharmaceutical companies for patented drugs are commonly several orders of magnitude higher than their marginal cost (the cost of producing an additional unit of the drug). For innovative products like antiretrovirals, private firms legitimately need to recover their high overhead costs for research and development and for fulfilling the regulatory prerequisites of market approval in high-income countries. This attributes a "temporary monopoly power" to the patent owner and creates socially useful long-term incentives for continued R&D.
5...
You must Login to view the entire paper.
If you are not a member yet, Sign Up for free!